Δ160p53 is a novel N-terminal p53 isoform encoded by Δ133p53 transcript

被引:116
作者
Marcel, Virginie [1 ]
Perrier, Stephane [1 ]
Aoubala, Mustapha [1 ]
Ageorges, Sylvain [2 ]
Groves, Michael J. [2 ]
Diot, Alexandra [1 ]
Fernandes, Kenneth [1 ]
Tauro, Sudhir [2 ]
Bourdon, Jean-Christophe [1 ]
机构
[1] Univ Dundee, Ninewells Hosp, INSERM European Associated Lab, Ctr Oncol & Mol Med, Dundee DD1 9SY, Scotland
[2] Univ Dundee, Ninewells Hosp & Med Sch, Dept Haematol, Dundee DD1 9SY, Scotland
来源
FEBS LETTERS | 2010年 / 584卷 / 21期
关键词
p53; Tumour suppressor; Delta; 160p53; 133p53; CELLS; GENE;
D O I
10.1016/j.febslet.2010.10.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p53 gene expresses several protein isoforms modulating p53-mediated responses through regulation of gene expression. Here, we identify a novel p53 isoform, Delta 160p53, lacking the first 159 residues. By knockdown experiments and site-directed mutagenesis, we show that Delta 160p53 is encoded by Delta 133p53 transcript using ATG160 as translational initiation site. This hypothesis is supported by endogenous expression of Delta 160p53 in U2OS, T47D and K562 cells, the latter ones carrying a premature stop codon that impairs p53 and Delta 133p53 protein expression but not the one of Delta 160p53. Overall, these results show that the Delta 133p53 transcript generates two different p53 isoforms, Delta 133p53 and Delta 160p53. (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:4463 / 4468
页数:6
相关论文
共 14 条
  • [1] AOUBALA M, 2010, CELL DEATH DIFF
  • [2] p53 isoforms can regulate p53 transcriptional activity
    Bourdon, JC
    Fernandes, K
    Murray-Zmijewski, F
    Liu, G
    Diot, A
    Xirodimas, DP
    Saville, MK
    Lane, DP
    [J]. GENES & DEVELOPMENT, 2005, 19 (18) : 2122 - 2137
  • [3] p53 isoform Δ113p53 is a p53 target gene that antagonizes p53 apoptotic activity via BclxL activation in zebrafish
    Chen, Jun
    Ng, Sok Meng
    Chang, Changqing
    Zhang, Zhenhai
    Bourdon, Jean-Christophe
    Lane, David P.
    Peng, Jinrong
    [J]. GENES & DEVELOPMENT, 2009, 23 (03) : 278 - 290
  • [4] ΔN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53
    Courtois, S
    Verhaegh, G
    North, S
    Luciani, MG
    Lassus, P
    Hibner, U
    Oren, M
    Hainaut, P
    [J]. ONCOGENE, 2002, 21 (44) : 6722 - 6728
  • [5] p53 isoforms Δ133p53 and p53β are endogenous regulators of replicative cellular senescence
    Fujita, Kaori
    Mondal, Abdul M.
    Horikawa, Izumi
    Nguyen, Giang H.
    Kumamoto, Kensuke
    Sohn, Jane J.
    Bowman, Elise D.
    Mathe, Ewy A.
    Schetter, Aaron J.
    Pine, Sharon R.
    Ji, Helen
    Vojtesek, Borivoj
    Bourdon, Jean-Christophe
    Lane, David P.
    Harris, Curtis C.
    [J]. NATURE CELL BIOLOGY, 2009, 11 (09) : 1135 - U208
  • [7] The first 30 years of p53: growing ever more complex
    Levine, Arnold J.
    Oren, Moshe
    [J]. NATURE REVIEWS CANCER, 2009, 9 (10) : 749 - 758
  • [8] p53 family members in cancer diagnosis and treatment
    Machado-Silva, Alice
    Perrier, Stephane
    Bourdon, Jean-Christophe
    [J]. SEMINARS IN CANCER BIOLOGY, 2010, 20 (01) : 57 - 62
  • [9] p53 regulates the transcription of its Δ133p53 isoform through specific response elements contained within the TP53 P2 internal promoter
    Marcel, V.
    Vijayakumar, V.
    Fernandez-Cuesta, L.
    Hafsi, H.
    Sagne, C.
    Hautefeuille, A.
    Olivier, M.
    Hainaut, P.
    [J]. ONCOGENE, 2010, 29 (18) : 2691 - 2700
  • [10] p53 isoforms - A conspiracy to kidnap p53 tumor suppressor activity?
    Marcel, V.
    Hainaut, P.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2009, 66 (03) : 391 - 406